Online citations, reference lists, and bibliographies.
← Back to Search

Archaeosome Immunostimulatory Vaccine Delivery System.

G. B. Patel, Wangxue Chen
Published 2005 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Archaeosomes are liposomes made from the polar ether lipids of Archaea. These lipids are unique and distinct in structure from the ester lipids found in Eukarya and Bacteria. The regularly branched and usually fully saturated isopranoid chains of archaeal polar lipids are attached via ether bonds to the sn-2,3 carbons of the glycerol backbone(s). The polar head groups are usually the same as those encountered in the ester lipids from the other two domains, except that phosphatidylcholine is rarely present. These lipid structures provide formulary advantages, and contribute to the excellent physico-chemical stability of the archaeosomes and their efficacy as self-adjuvanting vaccine delivery vesicles. The uptake of archaeosomes by phagocytic cells is several folds greater than that of liposomes made from ester lipids. In addition, archaeosomes enhance the recruitment and activation of professional antigen presenting cells in vivo, and deliver the antigen to both MHC class I and II pathways for antigen presentation, without eliciting overt inflammatory responses. In murine models, systemic administration of archaeosomes containing encapsulated antigen(s) elicits strong and sustained antigen-specific antibody responses which are comparable, in some formulations, to those obtained with Freund's adjuvant. Additionally, archaeosomes promote robust antigen-specific cell-mediated immunity, including CD8+ CTL responses. The immune responses induced by archaeosomes are sustained over long periods and exhibit strong memory responses. More importantly, immunization of mice with archaeosome-based vaccines induces robust protective immunity against intracellular pathogens, and prophylactic and therapeutic efficacies against the development of experimental cancers. Extensive murine model studies suggest that archaeosomes are safe.

This paper is referenced by
Potential of Nanocarriers in Antigen Delivery: The Path to Successful Vaccine Delivery
V. Patravale (2014)
Lipid-Based Nanocarriers for Lymphatic Transportation
Nikhar Vishwakarma (2019)
Bipolar tetraether archaeosomes exhibit unusual stability against autoclaving as studied by dynamic light scattering and electron microscopy.
Desmond A. Brown (2009)
Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
G. B. Patel (2007)
Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids.
J. Parmentier (2011)
Advances and challenges in mucosal adjuvant technology.
D. Newsted (2015)
Nanotherapeutic systems for delivering cancer vaccines: recent advances.
Sarwar Beg (2020)
Archaeosomes with encapsulated antigens for oral vaccine delivery.
Z. Li (2011)
Le rôle des archées dans l'inflammation et leur impact sur la santé humaine
P. B. Lecours (2014)
Delivery strategies of melanoma vaccines: an overview
Y. Lai (2008)
Nanotechnological Approaches for Genetic Immunization
A. Goyal (2013)
Improved oral bioavailability of bioactives through lipid-based nanoarchitectures**Declaration of Interest: The authors report no conflict of interest.
Udita Agrawal (2016)
Archaeosomes: an excellent carrier for drug and cell delivery
G. Kaur (2016)
Targeting the porcine immune system—Particulate vaccines in the 21st century
K. Mccullough (2009)
Liposomal-Based Therapeutic Carriers for Vaccine and Gene Delivery
Mahfoozur Rahman (2017)
Liposomal adjuvants: preparation and formulation with antigens.
J. Haensler (2010)
Archaeal lipid mucosal vaccine adjuvant and delivery system
G. B. Patel (2010)
Progress in Applications of Liposomes in Food Systems
W. Liu (2015)
Liposomal vaccine delivery systems
M. Henriksen-Lacey (2011)
A linear pathway for mevalonate production supports growth of Thermococcus kodakarensis
Geraldy L. S. Liman (2019)
New patents on mucosal delivery of vaccines
A. Goyal (2008)
Liposomes and Other Nanoparticles as Cancer Vaccines and Immunotherapeutics
J. Altin (2012)
Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles
A. Srivastava (2015)
Folate-equipped pegylated archaeal lipid derivatives: synthesis and transfection properties.
C. Lainé (2008)
Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
A. K. Giddam (2012)
Improved oral bioavailability of human growth hormone by a combination of liposomes containing bio-enhancers and tetraether lipids and omeprazole.
J. Parmentier (2014)
Archaeal tetraether bipolar lipids: Structures, functions and applications.
A. Jacquemet (2009)
DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases
V. Erdmann (2013)
Recent advancements in oral administration of insulin‐loaded liposomal drug delivery systems for diabetes mellitus
Chun Y Wong (2018)
Investigation of archaeosomes as carriers for oral delivery of peptides.
Z. Li (2010)
Innovation in Vaccinology
Selene Baschieri (2012)
The Role of CD8+ T Cell Phenotype and Cytotoxicity on Cancer Immunotherapy
Felicity C Stark (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar